Charles River Laboratories International, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2007 | — | $1.91B | $225.4M |
| FY2008 | — | $1.24B | $243.6M |
| FY2009 | $457.4M | $1.38B | $182.6M |
| FY2010 | $670.2M | $687.4M | $179.2M |
| FY2011 | $703.2M | $525.6M | $68.9M |
| FY2012 | $527.1M | $600.8M | $109.7M |
| FY2013 | $641.8M | $641.0M | $155.9M |
| FY2014 | $722.0M | $672.2M | $160.0M |
| FY2015 | $821.0M | $733.1M | $117.9M |
| FY2016 | $1.19B | $836.8M | $117.6M |
| FY2017 | $1.09B | $1.05B | $163.8M |
| FY2018 | $1.63B | $1.32B | $195.4M |
| FY2019 | $1.85B | $1.63B | $238.0M |
| FY2020 | $1.93B | $2.11B | $228.4M |
| FY2021 | $2.66B | $2.53B | $241.2M |
| FY2022 | $2.71B | $2.98B | $233.9M |
| FY2023 | $2.65B | $3.60B | $276.8M |
| FY2024 | $2.24B | $3.46B | $194.6M |
| FY2025 | $2.14B | $3.16B | $213.8M |